Pharmaceutical company Collegium Pharmaceutical (NASDAQ:COLL) will be reporting earnings tomorrow after the bell. Here’s what to look for. Collegium Pharmaceutical beat analysts’ revenue ...

CHERNIHIV, Ukraine — The 43-year-old Ukrainian actor took to the stage wearing a black leather jacket and with a moustache painted on her face. Ruslana Ostapko was performing in multiple ...

CHERNIHIV, Ukraine (AP) — The 43-year-old Ukrainian actor took to the stage wearing a black leather jacket and with a moustache painted on her face. Ruslana Ostapko was performing in multiple ...

In a report released today, David Amsellem from Piper Sandler reiterated a Hold rating on Collegium Pharmaceutical (COLL – Research Report), with a price target of $36.00. See what stocks are ...

The Russians struck Chernihiv Oblast on the night of 6-7 March, damaging a production facility in the Pryluky district. Source: Viacheslav Chaus, Head of Chernihiv Oblast Military Administration, on ...

Analysts on Wall Street project that Collegium Pharmaceutical (COLL) will announce quarterly earnings of $1.54 per share in its forthcoming report, representing a decline of 2.5% year over year.

The Neubauer Collegium for Culture and Society has announced nine new projects for 2025-26. Each year Collegium projects bring together University faculty and other researchers to work through ...

With Most Male Actors at War, a Small Ukrainian Theater Reinvents Itself With an All-Female Cast CHERNIHIV, Ukraine (AP) — The 43-year-old Ukrainian actor took to the stage wearing a black ...

Collegium Pharmaceutical Inc. is a specialty pharma company with strong cash flow, high EBITDA margins, and a focus on non-abusive painkillers and ADHD drugs. The new CEO has a proven track record ...

NEW DELHI: The Health Ministry has called the AIIMS Director for the review of the collegium system implemented in the institute last year. The Union Ministry had implemented this system to check ...

Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients ...

In this article, we are going to take a look at where Collegium Pharmaceutical, Inc. (NASDAQ:COLL) stands against the other small cap pharma stocks. Emily Field, Head of European Pharma Research ...